New study finds maternal vaccine and monoclonal antibody effective against RSV in infants Post author: Post published:January 10, 2024 Post category:uncategorized The impact and cost-effectiveness of maternal vaccination (MV) to long-acting monoclonal antibody (la-mAB) therapy. You Might Also Like Tracing the decline in American heart disease mortality January 21, 2026 New imaging technique boosts survival in prostate cancer patients October 14, 2025 Neuritin 1 unlocks new pathway to treat obesity without reducing food intake September 4, 2025